DENVER, Oct. 3 /PRNewswire-FirstCall/ -- Accelr8 Technology Corporation (OTC Bulletin Board: ACLY) announced today that its shares are expected to begin trading on the American Stock Exchange on or about October 9, 2003. Its new trading symbol will be (Amex: AXK). Accelr8 sells advanced microarray slides and specialty microtiter plates coated with its proprietary OptiChem(TM) activated surface chemistry. This surface has the extraordinary ability to eliminate unwanted background noise from bio-analytical performance by enabling higher sensitivity, greater reproducibility, and higher throughput by making it possible to eliminate processing steps such as protein blocking. Accelr8 Technology's vision is to compete in the general area of biosciences, including DNA/RNA assays, protein-based assays and biosensors. Accelr8's proprietary surface chemistry and its quantification instruments support real-time assessment of medical diagnostics, food borne pathogens, water borne pathogens and bio-warfare assessments. Certain statements in this news release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding future prospects and developments are based upon current expectations and involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking statement, including those detailed in the company's filings with the Securities and Exchange Commission.
SOURCE Accelr8 Technology Corporation